CNR Institutional Research Information System

FALCONE, GERMANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.214
NA - Nord America 681
EU - Europa 333
SA - Sud America 231
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 647
SG - Singapore 499
CN - Cina 269
BR - Brasile 177
VN - Vietnam 134
HK - Hong Kong 114
IT - Italia 108
FR - Francia 74
KR - Corea 56
DE - Germania 34
JP - Giappone 33
GB - Regno Unito 25
IN - India 25
BD - Bangladesh 23
NL - Olanda 21
AR - Argentina 19
MX - Messico 14
CA - Canada 13
FI - Finlandia 12
AT - Austria 10
EC - Ecuador 10
ID - Indonesia 10
ES - Italia 9
TR - Turchia 9
CL - Cile 8
CO - Colombia 8
PL - Polonia 8
MA - Marocco 6
PK - Pakistan 6
IL - Israele 5
JO - Giordania 5
SE - Svezia 5
ZA - Sudafrica 5
IQ - Iraq 4
PY - Paraguay 4
RU - Federazione Russa 4
TN - Tunisia 4
DK - Danimarca 3
EG - Egitto 3
IE - Irlanda 3
JM - Giamaica 3
LT - Lituania 3
PT - Portogallo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
HR - Croazia 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
VE - Venezuela 2
BG - Bulgaria 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GP - Guadalupe 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 2.481
Salva come PNG Salva come JPEG
Città #
Singapore 291
Santa Clara 202
Hong Kong 113
Hefei 104
San Jose 72
Beijing 59
Seoul 56
Ashburn 50
Lauterbourg 50
Rome 50
Ho Chi Minh City 48
Los Angeles 44
Dallas 43
Hanoi 36
Tokyo 22
Frankfurt am Main 20
Milan 15
New York 15
Orem 13
São Paulo 11
Rio de Janeiro 9
Buffalo 7
Chennai 7
Da Nang 7
Warsaw 7
Ankara 6
Atlanta 6
Brescia 6
Boston 5
Lappeenranta 5
Minamishinagawa 5
Naples 5
Nuremberg 5
Salvador 5
Stockholm 5
Verona 5
Amman 4
Amsterdam 4
Bengaluru 4
Chicago 4
Curitiba 4
Haiphong 4
Johannesburg 4
London 4
Manchester 4
Munich 4
Porto Alegre 4
Santiago 4
Shanghai 4
Toronto 4
Turku 4
Vienna 4
Acalanes Ridge 3
Belo Horizonte 3
Boardman 3
Bogotá 3
Brasília 3
Brooklyn 3
City of London 3
Columbia 3
Council Bluffs 3
Dublin 3
Guarulhos 3
Ha Long 3
Haarlem 3
Helsinki 3
Houston 3
Limeira 3
Monza 3
Ninh Bình 3
Paris 3
Philadelphia 3
Piracicaba 3
Poplar 3
Rabat 3
Roubaix 3
Tashkent 3
Thái Bình 3
Aarhus 2
Ahmedabad 2
Asunción 2
Baghdad 2
Bexley 2
Bắc Ninh 2
Cairo 2
Campinas 2
Capitão Poço 2
Columbus 2
Da Lat 2
Düsseldorf 2
Elgoibar 2
Elk Grove Village 2
Ezeiza 2
Falkenstein 2
Goiânia 2
Guayaquil 2
Guaçuí 2
Inzago 2
Istanbul 2
Jakarta 2
Totale 1.595
Salva come PNG Salva come JPEG
Nome #
BEHAVIOURAL ABNORMALITIES IN DMSXL MICE, A MODEL OF MYOTONIC DYSTROPHY TYPE 1 83
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of Myotonic Dystrophy type 1 83
Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1 79
Signaling by exosomal microRNAs in cancer 76
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells 73
Study of pathogenetic mechanisms and development of new therapeutic strategies for Myotonic Dystrophy type 1 71
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1 70
Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains 68
High-throughput analysis of the RNAinduced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2 67
Sleep-related phenotypes are non-invasively uncovered using home cage monitoring in mouse models of ALS and DM1 66
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 66
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 64
Inducible CRISPR/Cas9 strategy mediates efficient gene editing of trinucleotide repeat expansion in DMPK locus 63
Gene Therapy Strategies For Myotonic Dystrophy Type 1 62
Circular RNA role in Myotonic Dystrophy type 1 60
10. Role of cell division in differentiation of myoblasts infected with a temperature-sensitive mutant of Rous sarcoma virus. 59
Eps8, a tyrosine kinase substrate, is recruited to the cell cortex and dynamic F-actin upon cytoskeleton remodeling. 58
CRISPR/Cas9-mediated genomic deletions of trinucleotide repeats in Myotonic Dystrophy type 1: a new tool for gene therapy? 57
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing 51
CRISPR/Cas9-MediatedDeletion ofCTGExpansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients 50
Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring 48
Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells. 47
Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells 47
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 46
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1 46
SELECTIVE DISASSEMBLY OF SARCOMERIC STRUCTURES UPON REACTIVATION OF A TYROSINE KINASE IN QUAIL MYOTUBES 44
Time-controlled and muscle-specific CRISPR/Cas9 mediated deletion of CTG-repeat expansion in the DMPK gene 43
A new role of miR-29c as a potent inducer of skeletal muscle hypertrophy 40
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1 39
Circular RNAs in muscle function and disease 39
Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence 35
Regulation of the tyrosine kinase substrate Eps8 expression by growth factors, v-Src and terminal differentiation. 35
Noncoding RNAs: Emerging Players in Muscular Dystrophies 34
Transformation of NIH3T3 cells by Rous sarcoma virus occurs with high efficiency in the absence of proviral rearrangements or amplification. 33
Distinct effects of Rac1 on differentiation of primary avian myoblasts. 32
Induction of telomerase activity in v-myc-transformed avian cells. 32
The v-myc oncogene is sufficient to induce growth transformation of chick neuroretina cells. 32
Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes 31
Glucocorticoids modulate transformation by v-Src in a cell-specific manner. 31
MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells 31
Maintenance of skeletal muscle: role of mRNA post-transcriptional regulation. 29
Delineating v-Src downstream effector pathways in transformed myoblasts. 29
Retroviral oncogenes can block terminal differentiation of quail muscle cells through distinguishable mechanisms. 28
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels 27
Transcription of muscle-specific genes is repressed by reactivation of pp60v-src in postmitotic quail myotubes. 26
Remodeling of cytoskeleton and triads following activation of v-Src tyrosine kinase in quail myotubes. 26
Differential influence of adjacent normal cells on the proliferation of mammalian cells transformed by the viral oncogenes myc, ras and src. 25
Influence of adjacent normal cells on the proliferation of mammalian cells transformed by viral oncogenes - possible control by junctional intercellular communication 25
Fine regulation of RhoA and Rock is required for skeletal muscle differentiation. 24
Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells. 24
Prolonged Lifespan with Enhanced Exploratory Behavior in Mice Overexpressing the Oxidized Nucleoside Triphosphatase hMTH1. 24
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. 24
Tumor Promoters Enhance v-myc-induced Focus Formation in Mammalian Cell Lines. 23
Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells. 22
Title: THE V-SRC ONCOGENE AFFECTS MYOGENIC DIFFERENTIATION AT DIFFERENT LEVELS - IMPLICATION OF TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL MECHANISMS 22
Co-ordinator report, FIRB Project Molecole di segnalazione nel mantenimento dello stato differenziato di cellule muscolari , 2004-07 21
Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells. 21
Ras-genes and cellular transformation. 20
Partial transformation of mouse fibroblastic and epithelial cell lines with the v-myc oncogene. 16
Translational behavioral phenotypes in DMSXL mice for CNS manifestations of DM1 7
Totale 2.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.839
article - articoli 5.061
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 178
Totale 13.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202454 0 0 0 0 0 0 0 0 1 9 13 31
2024/2025904 8 5 71 36 194 31 25 48 51 28 218 189
2025/20261.596 96 160 184 248 269 85 220 69 79 116 70 0
Totale 2.554